Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.86 |
| ▸ | MEN1 | O00255 | 2/20 | 0.86 |
| ▸ | USP2 | O75604 | 2/20 | 0.86 |
| ▸ | TP53 | P04637 | 2/20 | 0.86 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.86 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.86 |
| ▸ | HPGD | P15428 | 1/20 | 0.86 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.86 |
| ▸ | HBB | P68871 | 1/20 | 0.86 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.86 |
| ▸ | APP | P05067 | 6/20 | 0.70 |
| ▸ | MAOB | P27338 | 2/20 | 0.69 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.69 |
| ▸ | MMP3 | P08254 | 2/20 | 0.66 |
| ▸ | MMP9 | P14780 | 2/20 | 0.66 |
| ▸ | IP6K2 | Q9UHH9 | 3/20 | 0.63 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.63 |
| ▸ | FLT3 | P36888 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 2/20 | 0.63 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sciadopitisin SCHEMBL30996894 | 1.00 | MAPT (0.86) | MAPTMEN1USP2TP53KMT2A | |
| Isoginkgetin SCHEMBL22459983 | 0.96 | MEN1 (0.80) | MAPTMEN1USP2TP53KMT2A | |
| Isoginkgetin SCHEMBL30293900 | 0.96 | MEN1 (0.80) | MAPTMEN1USP2TP53KMT2A | |
| Ginkgetin SCHEMBL31303838 | 0.96 | MAPT (0.86) | MAPTMEN1USP2TP53KMT2A | |
| Ginkgetin SCHEMBL888410 | 0.96 | MAPT (0.86) | MAPTMEN1USP2TP53KMT2A | |
| Ginkgetin SCHEMBL30612275 | 0.96 | MAPT (0.86) | MAPTMEN1USP2TP53KMT2A | |
| SCHEMBL22459584 | 0.94 | MAPT (0.77) | MAPTMEN1USP2TP53KMT2A | |
| SCHEMBL16888262 | 0.93 | MEN1 (0.76) | MAPTMEN1USP2TP53KMT2A | |
| Podocarpusflavone B SCHEMBL29496271 | 0.92 | MAPT (0.73) | MAPTMEN1USP2TP53KMT2A | |
| Podocarpusflavone B SCHEMBL27350627 | 0.92 | MAPT (0.73) | MAPTMEN1USP2TP53KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4609911-A2 | COMPOUNDS EFFECTIVE IN TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES AND USES THEREOF | Sinew Pharma Inc. (TW) | 2025-09-03 | — | — | EP | claimed |
| US-20250000924-A1 | Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2025-01-02 | — | — | US | claimed |
| US-20240335404-A1 | SUBSTITUTED ESTERS CONTAINING POLYOLS AND SACCHARIDES FOR TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES | SINEW PHARMA INC. (TW) | 2024-10-10 | — | — | US | claimed |
| US-12083088-B2 | Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases | SINEW PHARMA INC. (TW) | 2024-09-10 | — | — | US | claimed |
| EP-4401711-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| WO-2023043852-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. (US) | 2023-03-23 | — | — | WO | claimed |
| CN-115813906-A | Application of folium Ginkgo extract in preparing lysosome agonist and medicine or preparation for treating lysosome dysfunctional diseases | 贵州医科大学 | 2023-03-21 | — | — | CN | claimed |
| US-20230079480-A1 | STABLE NON-AQUEOUS COMPOSITIONS OF FUNCTIONAL INGREDIENTS AND METHODS OF MAKING THE SAME | Nulixir Inc. | 2023-03-16 | — | — | US | claimed |
| CN-115184493-A | Fingerprint detection method for active ingredients in taxus mairei medicinal material and traditional Chinese medicine decoction pieces thereof | 株洲市食品药品检验所 | 2022-10-14 | — | — | CN | claimed |
| CN-115112783-A | Ginkgo leaf detection method and construction and application of fingerprint spectrum with simultaneous reflection of multiple components | 江苏康缘药业股份有限公司 | 2022-09-27 | — | — | CN | claimed |
| WO-2012146592-A1 | CONTROLLED RELEASE TABLET OF GINKGO BILOBA EXTRACT AND PROCEDURE FOR OBTAINING IT | DR. WILLMAR SCHWABE GMBH & CO. KG (DE) | 2012-11-01 | — | — | WO | claimed |
| CN-102070589-B | Method for extracting sciadopitysin from laxus malrel leaves | NINGBO TAIKANG HONGDOUSHAN BIOLOG ENGINEERING CO LTD | 2012-05-30 | — | — | CN | claimed |
| EP-2329831-A2 | Stimulation of hair growth by Ginko biloba flavanoids | Osteoscreen, Inc. (US) | 2011-06-08 | — | — | EP | claimed |
| CN-102070589-A | Method for extracting sciadopitysin from laxus malrel leaves | NINGBO TAIKANG HONGDOUSHAN BIOLOG ENGINEERING CO LTD | 2011-05-25 | — | — | CN | claimed |
| EP-1868625-B1 | IMPROVED METHOD FOR PREPARING GINKGO EXTRACTS HAVING A LOW CONTENT OF 4'-O-METHYL PYRIDOXINE AND/OR BIFLAVONES | SCHWABE WILLMAR GMBH & CO (DE) | 2008-07-23 | — | — | EP | claimed |
| US-20080075794-A1 | Mixture of natural plant extracts comprising extracts from Taxus and Thymus; capable of strong antimicrobial ability as well as the elimination of foul odors | BAE CHANGSOON | 2008-03-27 | — | — | US | claimed |
| CN-1960698-A | Local slimming preparation and cosmetic containing carnitine derivative | SHOWA DENKO KK (JP) | 2007-05-09 | — | — | CN | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| CN-1397233-A | Natural Japanese yew beverage | LI MEISHENG (CN) | 2003-02-19 | — | — | CN | claimed |
| CN-1147552-A | Jew wine and its making process | ZHANG ZHENGLI (CN) | 1997-04-16 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250000924-A1 | Composition for the prevention, improvement or treatment of allergic disease comprising an extract of Taxus cuspidata as an active ingredient | SERPINB1, TSLP, CMA1 | MAPT 516/4885MEN1 4738/4885USP2 1721/4885 |
| US-20240335404-A1 | SUBSTITUTED ESTERS CONTAINING POLYOLS AND SACCHARIDES FOR TREATING HEPATOTOXICITY AND FATTY LIVER DISEASES | CPT1A, UGCG, UGGT1 | MAPT 4443/4885MEN1 4187/4885USP2 2434/4885 |
| US-12083088-B2 | Substituted esters containing polyols and saccharides for treating hepatotoxicity and fatty liver diseases | CPT1A, UGCG, UGGT1 | MAPT 4443/4885MEN1 4187/4885USP2 2434/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.